Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

NCT04217447 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04217447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04217447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Terminated
Start date
May 25, 2020
Completion date
October 28, 2024
Enrollment
874 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease